Rafferty Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Rafferty Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-234,625	Closed	-$9.3M	–	1205
2024 Q1	$9.3M	Buy	234,625 +154,463	+193%	+$4.56M	0.03%	292
2023 Q4	$1.53M	Buy	+80,162	New	+$1.11M	0.01%	737

Rafferty Asset Management's ALPN Position: Q2 2024 in Review

Rafferty Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 234,625 shares — an estimated $9.3M sold.

Rafferty Asset Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $9.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Rafferty Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Rafferty Asset Management sold 234,625 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $9.3M.
Rafferty Asset Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Rafferty Asset Management's Alpine Immune Sciences Inc position peaked at $9.3M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.